BioXcel Therapeutics (BTAI) to prioritize high-potential agitation market opportunities for BXCL501 in bipolar disorders, schizophrenia, and Alzheimer’s disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to BioXcel Therapeutics (BTAI) to prioritize high-potential agitation market opportunities for BXCL501 in bipolar disorders, schizophrenia, and Alzheimer’s disease
(NASDAQ: BTAI) Delayed: 0.07 --0 (-0%)
Previous Close $0.07    52 Week High $ 
Open $0.07    52 Week Low $ 
Day High $0.07    P/E N/A 
Day Low $0.07    EPS $ 
Volume 9,277,797